Age: | 6-17 |
Gender: |
Any
|
Healthy Volunteers: | No |
Keywords: | Peanut, Clinical Trial, Allergy, Peanut Allergy, Allergy Trial, monotherapy |
Type: | Phase II |
Target: |
15 Participants
|
The safety and efficacy of dupilumab for this use has not been evaluated by any regulatory authority.
We will go over all eligibility criteria during a screening visit.
Location |
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.